News Impact
REPL· last 90 days
REPLIMUNE GROUP INC
Backward-looking only. These statistics describe how the price moved after past news. They are not a prediction. Sample sizes are small, market context differs every day, and past performance does not predict future results. See methodology and disclaimer.
Bullish news (sentiment ≥ 0.3)
1articles
- Avg +24h
- +3.57%
- Avg +72h
- +2.07%
- Avg +7d
- +3.22%
Neutral news (−0.3 to 0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Bearish news (sentiment ≤ −0.3)
0articles
- Avg +24h
- —
- Avg +72h
- —
- Avg +7d
- —
Per-event price reaction · 1 events
- CNBC5/29/2026, 12:51:06 PMReplimune to resubmit twice-rejected drug for approval after FDA shakeupSentiment0.30Relevance100%+24h+3.57%+72h+2.07%+7d+3.22%
Not investment advice. See full disclaimer.